Clinical Trials Logo

Clinical Trial Summary

The main purpose of this project is to identify the medium-term prognostic factors for patients with Severe Acquired Brain Injuries and evaluate their impact. The secondary aim is to create a system of continuous assessment of the quality of care for each rehabilitation unit.


Clinical Trial Description

For each unit involved, it will be collected these data : - Structural and organizational data of the Rehabilitation Units for Severe Acquired Brain Injuries; - Detailed information on patients upon entering Rehabilitation Units for Severe Acquired Brain Injuries; - Detailed information on patients, re-evaluated 4 months after the acute event Statistical models will be implemented, in order to identify prognostic factors that could predict the probability to observe three events, which represent objectives of the rehabilitation process: decannulation, trunk control and total feeding by os. These events should be evaluated four months after the acute episode. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04905264
Study type Observational
Source Mario Negri Institute for Pharmacological Research
Contact Giulia Irene Ghilardi
Phone 035 4535389
Email giulia_irene.ghilardi@marionegri.it
Status Recruiting
Phase
Start date January 3, 2022
Completion date June 30, 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02525432 - Autologous Stem Cell Study for Adult TBI (Phase 2b) Phase 2
Recruiting NCT06081283 - Antiseizure Medication in Seizure Networks at Early Acute Brain Injury Phase 4
Recruiting NCT06370520 - Screening Emotions in Adolescents at the Hospital for mTBI
Completed NCT03362346 - Signal Analysis for Neurocritical Patients
Recruiting NCT03635736 - Acustocerebrography (ACG) in Severe Brain Injury
Recruiting NCT06367816 - Brain Recovery With Automated VEntilation